Friday, June 16, 2017 9:58:59 PM
Thats how it looks to me stealth. I mean why else would Zimmer's consulting surgeons be involved with trials? It would be one thing if they were consultants for a few major companies but no they are only Zimmer consults plus a couple smaller companies.
Then there is Terry Corbin who is involved with both trials and often works in Netherlands but lives near Zimmer Spine division & Medtronic as a freelance consultant.
I guess its entirely possible for Sonny to have recommended these guys because he was a Zimmer consulting surgeon then....but he also consulted for Medtronic & ConferMIS. Why no surgeons connected with those companies?
As i already said I think before 2013 Zimmer was curious and made suggestions for trials including suggesting certain individuals to head trial. Once the results were compiled for cascade I believe Zimmer chose to initiate a development deal similar to what it had with Implex. Followed with a deal for dental development in 2016 after they proved SiNi to be antibacterial.
Then there is Terry Corbin who is involved with both trials and often works in Netherlands but lives near Zimmer Spine division & Medtronic as a freelance consultant.
I guess its entirely possible for Sonny to have recommended these guys because he was a Zimmer consulting surgeon then....but he also consulted for Medtronic & ConferMIS. Why no surgeons connected with those companies?
As i already said I think before 2013 Zimmer was curious and made suggestions for trials including suggesting certain individuals to head trial. Once the results were compiled for cascade I believe Zimmer chose to initiate a development deal similar to what it had with Implex. Followed with a deal for dental development in 2016 after they proved SiNi to be antibacterial.
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
